MERGER AND CONTRIBUTION AND SHARE EXCHANGE AGREEMENT by and among BSKE LTD., TITAN PHARMACEUTICALS, INC., TTNP MERGER SUB, INC. and KE SDN BHD dated as of August 19, 2024Share Exchange Agreement • August 19th, 2024 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
This Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024 (this “Agreement”), is made and entered into by and among (i) BSKE Ltd., a Cayman Islands exempted company (“PubCo”), (ii) Titan Pharmaceuticals, Inc., a Delaware corporation (“Parent”), (iii) TTNP Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of PubCo (“Merger Sub” and, together with PubCo, each, individually, an “Acquisition Entity” and, collectively, the “Acquisition Entities”), and (iv) KE Sdn Bhd, a Malaysian private limited company (the “Company”).
